The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E

<h3>Background</h3><p dir="ltr">The rapid growth of Qatar in the last two decades has attracted a large influx of immigrant workers who mostly come from HEV-hyperendemic countries. Thus, we aim to investigate the prevalence of HEV among acute non-A-C hepatitis patients in...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Enas S. Al Absi (10976751) (author)
مؤلفون آخرون: Duaa W. Al-Sadeq (10976754) (author), Makiyeh Khalili (10976757) (author), Nadin Younes (4863280) (author), Nader Al-Dewik (4166527) (author), Sara K. Abdelghany (10976760) (author), Somaia S. Abouzid (10976763) (author), Asma A. Al Thani (10976766) (author), Hadi M. Yassine (4675846) (author), Peter V. Coyle (6837260) (author), Gheyath K. Nasrallah (9200525) (author)
منشور في: 2021
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513516673695744
author Enas S. Al Absi (10976751)
author2 Duaa W. Al-Sadeq (10976754)
Makiyeh Khalili (10976757)
Nadin Younes (4863280)
Nader Al-Dewik (4166527)
Sara K. Abdelghany (10976760)
Somaia S. Abouzid (10976763)
Asma A. Al Thani (10976766)
Hadi M. Yassine (4675846)
Peter V. Coyle (6837260)
Gheyath K. Nasrallah (9200525)
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Enas S. Al Absi (10976751)
Duaa W. Al-Sadeq (10976754)
Makiyeh Khalili (10976757)
Nadin Younes (4863280)
Nader Al-Dewik (4166527)
Sara K. Abdelghany (10976760)
Somaia S. Abouzid (10976763)
Asma A. Al Thani (10976766)
Hadi M. Yassine (4675846)
Peter V. Coyle (6837260)
Gheyath K. Nasrallah (9200525)
author_role author
dc.creator.none.fl_str_mv Enas S. Al Absi (10976751)
Duaa W. Al-Sadeq (10976754)
Makiyeh Khalili (10976757)
Nadin Younes (4863280)
Nader Al-Dewik (4166527)
Sara K. Abdelghany (10976760)
Somaia S. Abouzid (10976763)
Asma A. Al Thani (10976766)
Hadi M. Yassine (4675846)
Peter V. Coyle (6837260)
Gheyath K. Nasrallah (9200525)
dc.date.none.fl_str_mv 2021-06-15T03:00:00Z
dc.identifier.none.fl_str_mv 10.1186/s12876-021-01841-2
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/The_prevalence_of_HEV_among_non-A-C_hepatitis_in_Qatar_and_efficiency_of_serological_markers_for_the_diagnosis_of_hepatitis_E/25771530
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Medical microbiology
Non-A-C hepatitis
RT-PCR
Wantai ELISA
Test performance
Prevalence
Qatar
dc.title.none.fl_str_mv The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p dir="ltr">The rapid growth of Qatar in the last two decades has attracted a large influx of immigrant workers who mostly come from HEV-hyperendemic countries. Thus, we aim to investigate the prevalence of HEV among acute non-A-C hepatitis patients in Qatar; and to evaluate the performance of four dominant commercial serological assays for HEV diagnosis.</p><h3>Methods</h3><p dir="ltr">259 patients with non-A-C hepatitis were tested using the Wantai HEV-IgM, HEV-IgG, HEV-Ag ELISA kits, and the MP Biomedical HEV-Total Ab ELISA kit. ALT levels were tested and HEV RNA (viral loads) was performed using Taqman AmpliCube HEV RT-PCR kit (Mikrogen, Neuried, Germany). The performance of each kit was assessed according to the RT-PCR results.</p><h3>Results</h3><p dir="ltr">HEV-RNA was detected in 23.1% of the samples. Most of these HEV-RNA-positive cases belonged to non-Qatari residents from the Indian subcontinent; India, Pakistan, etc. HEV-Ag, HEV-IgM, HEV-IgG, HEV-Total Ab were detected in 5.56%, 8.65%, 32.1%, and 34.2% of all tested samples, respectively. Elevated ALT levels were highly correlated with the HEV-Ag, HEV-IgM, HEV-RNA but not with the HEV-IgG and HEV-Total Ab. Although HEV-Ag was very specific (100%), yet its sensitivity was poor (36.7%). HEV-IgM demonstrated the best second marker for diagnosis of acute HEV after RT-PCR as jugged by the overall performance parameters: specificity (96.2%), sensitivity (71.4%), PPV (83.3%), NPP (92.7%), agreement with RT-PCR (91.0%), and Kappa-value (0.71).</p><h3>Conclusion</h3><p dir="ltr">Our study demonstrated a high prevalence of HEV virus in Qatar, mostly among immigrants from the Indian subcontinent. The HEV-IgM represents the best marker for detecting the acute HEV infection, where RT-PCR cannot be performed.</p><h2>Other Information</h2><p dir="ltr">Published in: BMC Gastroenterology<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12876-021-01841-2" target="_blank">https://dx.doi.org/10.1186/s12876-021-01841-2</a></p>
eu_rights_str_mv openAccess
id Manara2_450adf053415d74fa0eb8d74ad2f454c
identifier_str_mv 10.1186/s12876-021-01841-2
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25771530
publishDate 2021
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis EEnas S. Al Absi (10976751)Duaa W. Al-Sadeq (10976754)Makiyeh Khalili (10976757)Nadin Younes (4863280)Nader Al-Dewik (4166527)Sara K. Abdelghany (10976760)Somaia S. Abouzid (10976763)Asma A. Al Thani (10976766)Hadi M. Yassine (4675846)Peter V. Coyle (6837260)Gheyath K. Nasrallah (9200525)Biomedical and clinical sciencesMedical microbiologyNon-A-C hepatitisRT-PCRWantai ELISATest performancePrevalenceQatar<h3>Background</h3><p dir="ltr">The rapid growth of Qatar in the last two decades has attracted a large influx of immigrant workers who mostly come from HEV-hyperendemic countries. Thus, we aim to investigate the prevalence of HEV among acute non-A-C hepatitis patients in Qatar; and to evaluate the performance of four dominant commercial serological assays for HEV diagnosis.</p><h3>Methods</h3><p dir="ltr">259 patients with non-A-C hepatitis were tested using the Wantai HEV-IgM, HEV-IgG, HEV-Ag ELISA kits, and the MP Biomedical HEV-Total Ab ELISA kit. ALT levels were tested and HEV RNA (viral loads) was performed using Taqman AmpliCube HEV RT-PCR kit (Mikrogen, Neuried, Germany). The performance of each kit was assessed according to the RT-PCR results.</p><h3>Results</h3><p dir="ltr">HEV-RNA was detected in 23.1% of the samples. Most of these HEV-RNA-positive cases belonged to non-Qatari residents from the Indian subcontinent; India, Pakistan, etc. HEV-Ag, HEV-IgM, HEV-IgG, HEV-Total Ab were detected in 5.56%, 8.65%, 32.1%, and 34.2% of all tested samples, respectively. Elevated ALT levels were highly correlated with the HEV-Ag, HEV-IgM, HEV-RNA but not with the HEV-IgG and HEV-Total Ab. Although HEV-Ag was very specific (100%), yet its sensitivity was poor (36.7%). HEV-IgM demonstrated the best second marker for diagnosis of acute HEV after RT-PCR as jugged by the overall performance parameters: specificity (96.2%), sensitivity (71.4%), PPV (83.3%), NPP (92.7%), agreement with RT-PCR (91.0%), and Kappa-value (0.71).</p><h3>Conclusion</h3><p dir="ltr">Our study demonstrated a high prevalence of HEV virus in Qatar, mostly among immigrants from the Indian subcontinent. The HEV-IgM represents the best marker for detecting the acute HEV infection, where RT-PCR cannot be performed.</p><h2>Other Information</h2><p dir="ltr">Published in: BMC Gastroenterology<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12876-021-01841-2" target="_blank">https://dx.doi.org/10.1186/s12876-021-01841-2</a></p>2021-06-15T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s12876-021-01841-2https://figshare.com/articles/journal_contribution/The_prevalence_of_HEV_among_non-A-C_hepatitis_in_Qatar_and_efficiency_of_serological_markers_for_the_diagnosis_of_hepatitis_E/25771530CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/257715302021-06-15T03:00:00Z
spellingShingle The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
Enas S. Al Absi (10976751)
Biomedical and clinical sciences
Medical microbiology
Non-A-C hepatitis
RT-PCR
Wantai ELISA
Test performance
Prevalence
Qatar
status_str publishedVersion
title The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
title_full The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
title_fullStr The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
title_full_unstemmed The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
title_short The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
title_sort The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E
topic Biomedical and clinical sciences
Medical microbiology
Non-A-C hepatitis
RT-PCR
Wantai ELISA
Test performance
Prevalence
Qatar